Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: HPBCD

November 12, 2026 CD derivatives / Non-pharma applications / Other industrial use

Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar

Synthetic-based plasticizers are often used in the masonry industry to improve the rheological and mechanical properties of mortar, but these

Continue reading

November 11, 2026 Drug delivery / Pharma applications

Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief

A fast-dissolving nanofibrous film based on cyclodextrin (hydroxypropyl-β-cyclodextrin) inclusion complexes (ICs) incorporating a triple drug combination of acetylsalicylic acid (Aspirin),

Continue reading

November 2, 2026 CD as API / Pharma applications

Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C

Rafael Holdings, Inc. (NYSE: RFL) announced on Oct. 29 that its subsidiary, Cyclo Therapeutics, LLC, has submitted a New Drug

Continue reading

October 21, 2026 Cosmetics and toilettry / Non-pharma applications

Enhancing Sunscreens: HPβCD Improves Ferulic Acid Efficacy

Researchers from Brazil 🇧🇷 developed a HPβCD-based system to improve the stability, safety, and antioxidant activity of ferulic acid for

Continue reading

October 15, 2026 Drug delivery / Pharma applications

HPBCD–myrrh oil inclusion complex: enhancing solubility and antibacterial activity

Poor aqueous solubility limits the use of myrrh oil in antibacterial aqueous formulations. Here, a hexane extract of Commiphora myrrh

Continue reading

October 8, 2026 CD as API / CD derivatives / Pharma applications

Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC) concluded

The global, double-blind, placebo-controled Phase 3 TransportNPC™ study (CTD-TCNPC-301) enroled 94 patients with NPC, ranging in age from 3 to

Continue reading

October 1, 2026 CD derivatives / Drug delivery / Life sciences

Cyclodextrins may help a therapeutic agent en route to the brain

From curcuminoid solubilization to potential boron neutron capture therapy for Alzheimer’s disease What if a cyclodextrin could help take a

Continue reading

September 24, 2026 Drug delivery / Pharma applications

Paul Janssen was born 100 years ago

Probably, the most creative and productive pharmaceutical chemist of all time, Dr. Paul Adriaan Jan Janssen, was born 100 years

Continue reading

September 17, 2026 Analysis / CD derivatives

Tailoring cyclodextrin platforms for nanomolar range fluorescence detection of 1-hydroxypyrene as biomarker of polycyclic aromatic hydrocarbons

Polycyclic aromatic hydrocarbons (PAHs) are widespread combustion-derived pollutants, and 1-hydroxypyrene (1HOPy) is the standard biomarker used to track human exposure

Continue reading

September 15, 2026 Drug delivery / Pharma applications

HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms

This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient

Continue reading

Posts pagination

1 2 3 … 32 Next Posts»

Recent Posts

  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief
  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (444)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (834)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,243)
  • Supramolecular systems (45)
  • Uncategorized (177)

Top Posts

  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
  • Launch of KLEPTOSE® Crysmeb Methyl-Beta-Cyclodextrin for Oral and Parenteral Formulations
  • Pilocarpine eye drops (Vuity)
  • A Mix of β-Cyclodextrin and Lactic Acid for Greener Aroma Solutions
  • NO-delivering fluorescent beta-cyclodextrin polymer
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • 1-Methylcyclopropene: from the CD cavity to the apple tree
  • New book on cyclodextrin glucanotransferase
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,471 other subscribers
Loading Comments...